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ABSTRACT
The disposition kinetics of kanamycin was investigated following an injection of a single
intravenous dose 5 mg/kg body mass in healthy adult female mules. Blood samples collected at various
time intervals post-medication were analyzed for kanamycin by microbiological assay. The plasma
drug concentration versus time data was best fitted by a biexponential expression. Macro-kinetic
parameters were computed for a two-compartment open model. Values for distribution half-life (t1/2á))
and elimination half-life (t1/2 ß) were 0.18 ± 0.26 and 4.39 ± 0.68 h, respectively. The apparent volume
of distribution (Vd) was 0.64 ± 0.17 L/kg. Total body clearance (ClB) of the drug was 1.66 ± 0.22 ml/
min.kg. Existing dosage of 5 mg/kg body mass at 24 h intervals does not maintain the desired minimum
inhibitory concentration (MIC) at the end of proposed dosing intervals. Calculated optimal dosage
regimen for kanamycin in mules was 8.73 and 7.45 mg/kg body mass for priming and maintenance,
respectively, for a dosage interval of 12 h to maintain the concentration of 2 µg/ml in blood.
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Introduction
Most developing countries are importing either raw active substance
or finished drugs for human and veterinary use. Dosage regimens for these
drugs are often based on studies carried out in foreign environments and
species of animals. Generally speaking, in drug-importing countries
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environmental conditions and the genetic make-up of indigenous animals
which affect the biodisposition and fate of drugs are different from their
foreign counterparts. These differences are described by the original term
“geonetics” (NAWAZ and SHAH, 1985; NAWAZ et al., 1988; NAWAZ, 1994). As a
consequence of geonetical variations the optimal therapeutic usage of
imported drugs should be determined in both the target species and their
environments.
Kanamycin is an extensively used antibiotic for susceptible infections
in animals. Mules are important draught animals. Therefore, the disposition
kinetics of kanamycin was investigated in order to propose an optimal
intravenous dosage regimen of the drug.
Materials and methods
The disposition kinetics of kanamycin was investigated during the
month of April in 8 healthy adult female mules maintained on a farm at
Sargodha, Pakistan. Average body mass of the mules was 386 kg (range
375–410 kg). Animals were kept under similar management conditions.
Prior to drug administration a control blood sample was drawn from the
jugular vein and each animal was given kanamycin in a single intravenous
dose of 5 mg/kg. b.m. (Kanachron® 10%, Batch No. VD 124, Star
Laboratories, Lahore, Pakistan Ltd.). Blood samples were collected in
heparinized centrifuge tubes at 5, 10, 15, 30, 60 minutes and then at 1.5, 2,
2.5, 3, 4, 6, 8, and 10 hours after drug administration. Blood samples were
centrifuged at 500 × g for 10 minutes and plasma was separated and stored
at freezing point until analysis.
Concentration of kanamycin in plasma was determined by
microbiological assay (ARRET et al., 1971) using Staphylococcus aureus as
a test organism. Standard curves of kanamycin 1, 2, 4, 6, 8 mg/ml in plasma
and distilled water when plotted against the zone of inhibition revealed
regression equation y = 0.5395e0.2482x and a value of R2 = 0.9754. The
plasma concentration versus time data was used to calculate several
pharmacokinetics parameters using a PC program, MWPHARM version
3.02, a MEDIWARE product, Holland. This program calculates area under
curve (AUC) from time t to a by polyexponential and trapezoidal rule
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methods and the regression coefficient of best-fit to depict the
compartmental analysis for pharmacokinetic parameters (BAGGOT, 1977).
The pharmacokinetic parameters were used to calculate the optimal dosage
regimen for kanamycin in mules.
Results and discussion
Plasma concentration of kanamycin versus time data plotted on a
semilog scale depicted a biexponential decline (Fig. 1). This is similar to
that noted in other species, such as the horse, dog and sheep (BAGGOT,
1978), sheep, goat, rabbit, chicken and pigeon (LASHEV et al., 1992) and cattle
(GHAFFAR et al., 1996). Average ± SD values of the pharmacokinetic












 The elimination half-life of kanamycin in mules of 4.39 hours was
longer than the 1.4 hours in horse, 1.65 hrs in sheep, 0.74 hour in dog
(BAGGOT, 1977); 1.8 hours in the horse (BAGGOT et al., 1981); 2.36 hours in
buffaloes (FUHUA et al., 1989); 1.81 hours in sheep, and 1.95 hour in goats
Fig. 1. Average plasma concentration (µg/ml) of kanamycin in mules against time after
single (i/v) injection of 5 mg/kg body mass
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(LASHEV et al., 1992). The apparent volume of distribution (Vd) calculated
by the area method was 0.64 L/kg, which is higher than 0.17 L/kg in horse,
0.23 L/kg in dog and 0.22 L/kg in sheep (BAGGOT et al., 1977), and 0.23 L/
kg in horse (BAGGOT et al., 1985). The difference was due to a lower value
of “B”, the extrapolated zero time plasma drug concentration of the
elimination phase in mules. Total body clearance (ClB) of kanamycin in
mules was 1.66 ml/min.kg, which is comparable with ClB 1.43 ml/min.kg
in the horse, 1.52 ml/min.kg in sheep (BAGGOT, 1977); 1.48 ml/min.kg in
horse (BAGGOT et al., 1981), and 1.5 ml/min.kg in the dog (BAGGOT, 1977),
and 1.67 ml/min.kg in buffalo heifers (MUHAMMAD et al., 1999).
Based on the pharmacokinetics of kanamycin, a dosage regimen was
calculated considering 2 mg/ml as the optimum minimum inhibitory
concentration (MIC) for most equine pathogens (BAGGOT et al., 1985).
Priming and maintenance doses were calculated as 8.73 and 7.45 mg/kg
b.m., respectively, with a dosing interval of 12 hours to maintain the target
Kinetic parameters Units Average ± SD 
C°P µg/ml 22.1 ± 7.95 
A µg/ml 14.2 ± 6.65 
B µg/ml 7.91 ± 2.07 
α h-1 9.64 ± 5.98  
β h-1 0.16 ± 0.02 
t1/2α h 0.18 ± 0.26 
t1/2ß  h 4.39 ± 0.68 
Ke1 h-1 0.76 ± 0.87 
K12 h-1 5.83 ± 4.15 
K21 h-1 3.49 ± 1.92 
Vc L/kg 0.25 ± 0.09 
Vd(area) L/kg 0.64 ± 0.17 
Vdss L/kg 0.60 ± 0.13 
ClB  m1/min.kg 1.66 ± 0.22 
 
Table 1. Pharmacokinetic parameters of kanamycin following a single intravenous
injection of 5 mg/kg b. w. in 8 female mules
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trough MIC of 2 mg/ml. These doses are similar to 5 to 12 mg/kg/12 hours
in cattle, sheep, dog and pigs (BOOTH and McDONALD, 1988) and 10.3 mg/
kg/12 hours and 8.4 mg/kg/12 hours in cows for priming and maintenance
doses, respectively, (GHAFFAR et al., 1996), but higher than the manufacturer’s
recommendation of 5 mg/kg/24 hours. Compared with the manufacturer’s
recommended dosage regimen of 5 mg/kg/d, the clinical appraisal of dose
7.5 to 10 mg/kg b.i.d. in the Faculty’s Veterinary Hospital revealed improved
therapeutic response in equines, with no indication of toxicity in the
animals.
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SAŽETAK
Istražena je farmakokinetika raspodjele kanamicina u zdravih, odraslih mula nakon jednokratne
intravenske primjene u dozi 5 mg/kg tjelesne mase (t.m.) u zdravih odraslih mula. Uzorci krvi uzeti u
razlièitim vremenskim razmacima bili su pretraženi na kolièinu kanamicina mikrobiološkim testom.
Koncentracija lijeka u plazmi u odnosu na vrijeme najviše je odgovarala bieksponencijalnoj krivulji.
Za izraèunavanje farmakokinetièkih pokazatelja rabljen je dvoprostorni otvoreni model. Rezultati su
pokazali da je poluvrijeme raspodjele lijeka (t1/2α) iznosilo 0.18 ± 0.26, a poluvrijeme eliminacije
(t1/2β) 4.39 ± 0.68 sati. Prividni volumen raspodjele lijeka (Vd) bio je 0.64 ± 0.17 l/kg, a ukupni klirens
(ClB) 1.66 ± 0.22 ml/min/kg. Dozom 5 mg/kg t.m. jedanput na dan nije postignuta željena minimalna
inhibicijska koncentracija (MIC) na kraju doznog razmaka. Izraèunato je da je optimalna udarna doza
kanamicina za mule iznosila  8.73, a doza održavanja 7.45 mg/kg t.m. Pritom se lijek mora primjenjivati
svakih 12 sati da bi se postigla koncentracija u krvi 2 mg/ml.
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